Fig. 1From: Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanismsEvolution of thyroid function during durvalumab-associated thyroiditis. Mild thyrotoxicosis evolved into hypothyroidism requiring levothyroxine replacement therapy. The thyroid function tests eventually evolved favourably after insistence on adequate therapeutic complianceBack to article page